GLP-1 agonists like Ozempic are showing promise in reducing cravings for alcohol, nicotine, and various drugs.
The lateral septum in the brain is identified as a potential key region where these drugs exert anti-addiction effects.
The lateral septum processes reward-related information and contains a high density of GLP-1 receptors.
New research into brain connectivity is shifting the focus of addiction treatment toward these specific neural pathways.